Company Data
Pliant Therapeutics Inc.
Ticker
PLRX
Current Price
$1.19 -22.73%
Market Cap
$73.1M
Price Target
Refer to Report
Volume
10.8M
52wk Range
$1.1001 - $15.8
Overview
Pliant Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis. Its lead product candidate, PLN-74809, is an oral small-molecule dual that helps in the treatment of idiopathic pulmonary fibrosis.